Although physicians have looked for cutaneous signs of liver disease for more than a century, their prognostic value has never been evaluated systematically. Therefore, cutaneous changes were prospectively recorded in all patients referred for liver biopsy from June 2000 to May 2004. Fibrosis was ...
This prospective study aims to determine the prevalence and utility of clinical stigmata of chronic liver disease (CLD)in a high-risk cohort. Methods: Patients with chronic hepatitis B (CHB) and hepatitis C (CHC) undergoing liver stiffness measurement (LSM) using transient elastography (Fibroscan ...